Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials (Q36955489)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2007

Language	Label	Description	Also known as
English	Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials	scientific article published on September 2007

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

0 references

1 reference

Europe PubMed Central

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials (English)

1 reference

Europe PubMed Central

17 August 2017

type 2 diabetes

0 references

0 references

0 references

circulatory system

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Rodrigo M Lago

1

1 reference

Europe PubMed Central

17 August 2017

Premranjan P Singh

2

1 reference

Europe PubMed Central

17 August 2017

Richard W Nesto

3

1 reference

Europe PubMed Central

17 August 2017

language of work or name

0 references

publication date

1 September 2007

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

370

1 reference

Europe PubMed Central

17 August 2017

1129-1136

1 reference

Europe PubMed Central

17 August 2017

9593

1 reference

Europe PubMed Central

17 August 2017

Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinediones and risk of repeat target vessel revascularization following percutaneous coronary intervention: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Vascular effects of TZDs: new implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The DREAM trial – Authors' reply

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjudication of serious heart failure in patients from PROactive

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of various diuretic treatments on rosiglitazone-induced fluid retention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of diabetes on cardiac structure and function: the strong heart study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Echocardiographic detection of early diabetic myocardial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart failure associated with preserved systolic function: a common and costly clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice. Diastolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ventricular pump function in heart failure with normal ejection fraction: insights from pressure-volume measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiazolidinediones and Heart Failure: A teleo-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961514-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)61514-1

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36955489&oldid=1664466616"